News
Aquestive Therapeutics' Anaphylm offers a unique, non-injectable epinephrine solution for anaphylaxis. Read why AQST stock is ...
AnaptysBio, Inc.'s rosnilimab shows promise in RA & ulcerative colitis, targeting $20B+ markets. Phase 2b results highlight ...
Additionally, in the press release, Dan Schuchinsky, managing director at Jadian Capital, revealed the company plans to ...
After a pair of solo home runs in the first two batters started Horace off fast, the Mandan baseball team rallied and earned fifth place in the North Dakota Class ...
AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis: San Diego Thursday, June 5, 2025, 18:00 Hrs [IST] AnaptysBio, Inc., a clinic ...
A hacker claims to sell 1.2 billion Facebook records. Meta says it's old, but experts warn the data is real and dangerous.
Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
Favorable safety and tolerability, particularly when compared to standard of care biologics or JAKs Max response rates have not yet been observed; strict continuation criteria at three months in this ...
Circle IPO targets $7.2B, Saylor adds 705 BTC, and Tether launches a gold stablecoin—what does this mean for the crypto ...
Apt. 2B” puts a new spin on the Sherlock Holmes detective stories — and a lot more. It’s onstage at Osceola Arts.
Rideshare, delivery and digital ad taxes were left out of Illinois’ new budget, but business leaders warn the fight could ...
The federal government says it’s freezing more than $2.2 billion in grants and $60 million in contracts to Harvard University, after the institution said it would defy the Trump administration ...
Nevadans will soon have a new way to represent their school spirit on the highway. A new specialty license plate honoring Nevada State University has officially been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results